Jennison Associates’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Jennison Associates’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,775	Closed	-$653K	–	723
2017 Q2	$653K	Buy	5,775 +44	+0.8%	+$4.92K	﹤0.01%	597
2017 Q1	$574K	Sell	5,731 -13	-0.2%	-$1.39K	﹤0.01%	602
2016 Q4	$618K	Buy	5,744 +4,079	+245%	+$477K	﹤0.01%	653
2016 Q3	$207K	Sell	1,665 -732	-31%	-$86.4K	﹤0.01%	649
2016 Q2	$255K	Hold	2,397	–	–	﹤0.01%	626
2016 Q1	$274K	Hold	2,397	–	–	﹤0.01%	600
2015 Q4	$341K	Hold	2,397	–	–	﹤0.01%	644
2015 Q3	$215K	Hold	2,397	–	–	﹤0.01%	718
2015 Q2	$276K	Buy	+2,397	New	+$252K	﹤0.01%	726

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Jennison Associates's CBPO Position: Q3 2017 in Review

Jennison Associates sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 5,775 shares — an estimated $653K sold.

Jennison Associates first reported a position in CBPO in Q2 2015 and held it in 9 quarters. The position peaked at $653K in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

Jennison Associates reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
Jennison Associates sold 5,775 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $653K.
Jennison Associates first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 9 quarters.
Jennison Associates's China Biologic Products Holdings, Inc. position peaked at $653K in Q2 2017.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.